The report by Chan et al1 in the current issue (p. 2278) details how screening for both diabetic retinopathy and age-related macular degeneration (AMD) can be conducted using fundus photographs obtained with nonmydriatic cameras. Exactly how cost-effective is such a screening? Could this be a recommendation for the future? Herein, we explore the potential for such a model for the management of 2 of the leading causes of blindness worldwide.
Powered by Versicherungsvergleich